Natural Killer Cell Inhibitory Receptors Block Actin Cytoskeleton-dependent Recruitment of 2B4 (CD244) to Lipid Rafts by Watzl, Carsten & Long, Eric O.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
The Journal of Experimental Medicine • Volume 197, Number 1, January 6, 2003 77–85
http://www.jem.org/cgi/doi/10.1084/jem.20020427
 
77
 
Natural Killer Cell Inhibitory Receptors Block Actin 
Cytoskeleton-dependent Recruitment of 2B4 (CD244) to 
Lipid Rafts
 
Carsten Watzl
 
1, 2
 
 and Eric O. Long
 
1
 
1
 
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 
Rockville, MD 20852
 
2
 
Institute for Immunology, University Heidelberg, INF 305, 69120 Heidelberg, Germany
 
Abstract
 
A dynamic balance of positive and negative signals regulates target cell lysis by natural killer
(NK) cells upon engagement of a variety of different activation receptors and of inhibitory re-
ceptors that recruit the tyrosine phosphatase SHP-1. However, the step at which activation sig-
nals are blocked by SHP-1 is not known. We have been using activation receptor 2B4
(CD244) to study the influence of inhibitory receptors on NK cell activation. Engagement of
inhibitory receptors by HLA class I on target cells blocks phosphorylation of 2B4, placing the
inhibitory step at the level, or upstream of 2B4 phosphorylation. Here we show that phos-
phorylated 2B4, after engagement with either antibodies or target cells that express the 2B4
ligand, is found exclusively in a detergent-resistant membrane fraction that contains lipid rafts.
Integrity of lipid rafts was essential for phosphorylation and activating function of 2B4. Coen-
gagement of inhibitory receptors blocked 2B4 phosphorylation and 2B4 association with deter-
gent-resistant membranes, indicating that inhibitory receptors function upstream of raft-depen-
dent signals. Recruitment of 2B4 into detergent-resistant membrane fractions and 2B4
phosphorylation were dependent on actin polymerization. Blocking actin cytoskeleton-depen-
dent raft recruitment of different receptors may be a general mechanism by which inhibitory
receptors control NK cell activation.
Key words: natural killer cell • raft • tyrosine phosphorylation • inhibitory receptor • activation
 
Introduction
 
NK cells are large, granular lymphocytes that mediate lysis
of certain virally infected cells or tumor cells (1, 2). The ac-
tivity of NK cells is regulated by the expression of MHC
class I on potential target cells (3). Loss of MHC class I ex-
pression can render cells sensitive to NK cell attack. En-
counter with sensitive target cells induces a series of signals
in NK cells leading to target cell adhesion, polarization of
surface receptors and signaling molecules at the NK:target
cell interface, followed by the polarization and exocytosis
of granules toward the target cell, and the production of
cytokines such as interferon 
 
 
 
. The interface that forms be-
tween NK and target cells is referred to as the ‘NK immu-
nological synapse’, where adhesion molecules, other surface
receptors, and cytoplasmic signaling molecules are recruited
in an ordered manner (4–6). Formation of the NK immu-
nological synapse is paralleled by the polarization of lipid
rafts (7, 8), cholesterol-rich membrane microdomains that
have been implicated in NK cell activation (7). Rafts facili-
tate signal transduction by serving as platforms to concen-
trate surface receptors, signaling molecules such as Src-fam-
ily kinases, and adaptor molecules such as linker for
activation of T cells (LAT),
 
*
 
 in the otherwise fluid mem-
brane (9, 10).
Activation of NK cells is mediated by a variety of differ-
ent surface receptors. In humans, activating receptors in-
clude NKp46, NKp30, NKp44, and NKG2D (11, 12).
These receptors pair with signal-transducing partner chains
such as CD3
 
 
 
, Fc
 
 
 
RI
 
 
 
, DAP12, and DAP10. Another class
of activating NK cell receptors such as 2B4 (CD244), CS1,
NTB-A, and NKp80 carry tyrosine-based signaling motifs
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in their own cytoplasmic tail (13–15). We are only begin-
ning to understand the process of NK cell activation as the
ligands for several NK cell activating receptors are still un-
known. Human NKG2D has several ligands, including
ULBPs and the stress-inducible molecules MICA and
MICB (16, 17). 2B4 binds to CD48, which is widely ex-
pressed in the hematopoietic system (18, 19).
2B4 is expressed on all NK cells, on macrophages, and
on a subset of CD8
 
 
 
 T cells (20). Engagement of 2B4 by
antibodies or by its ligand CD48 induces natural cytotox-
icity and interferon 
 
 
 
 production (21–24). 2B4 enhances
signals from other activating receptors such as NKp46 (25)
and KIR2DL4 (26), therefore facilitating optimal NK cell
activation. 2B4 contains four tyrosine-based activation
motifs (TxYxxI/V) in its cytoplasmic tail and becomes ty-
rosine phosphorylated by Src-family kinases upon contact
with CD48-expressing target cells (24). After phosphor-
ylation, 2B4 binds the signaling molecules SAP, SHP-1,
and SHP-2 (23, 27). 2B4 associates with the adaptor mole-
cule LAT (28, 29). However, it is not known how the as-
sociation of those molecules with 2B4 contributes to NK
cell activation.
Expression of MHC class I can protect target cells from
NK cell cytotoxicity. This protection is mediated by inhib-
itory NK cell receptors that recognize target cell MHC
class I (3). The inhibitory receptors expressed on human
NK cells belong either to the killer cell Ig-like receptor
family (KIR) or to a family of lectin-like receptors (CD94/
NKG2). Recognition of MHC class I on target cells leads
to the phosphorylation of immunoreceptor tyrosine-based
inhibition motifs (ITIMs) in the cytoplasmic tail of the re-
ceptors, resulting in the recruitment of the tyrosine phos-
phatase SHP-1 (30). The activity of SHP-1 is essential for
the inhibition of NK cell activation.
How do inhibitory receptors block NK cell activation
mediated by a variety of different activating receptors? Us-
ing 2B4 and its known ligand CD48 as a model system we
have shown that 2B4-mediated NK cell activation can be
blocked by KIR and by CD94/NKG2A (24). Coengagement
of 2B4 and inhibitory receptors prevents 2B4 phosphoryla-
tion (24), placing the inhibitory effect of ITIM-bound
SHP-1 at the level, or upstream of 2B4 phosphorylation.
To investigate the effect of inhibitory receptors on NK cell
activation in more detail the signaling events leading to
2B4 phosphorylation were studied. Here we show that the
actin cytoskeleton-dependent recruitment of 2B4 into clus-
tered lipid rafts, as determined by association with a deter-
gent-resistant membrane (DRM) fraction (9), is essential
for 2B4 phosphorylation and function, and that raft recruit-
ment of 2B4 is blocked by inhibitory receptors.
 
Materials and Methods
 
Cell Lines and Culture.
 
Human polyclonal NK cells were iso-
lated from PBL using the MACS NK cell isolation kit (Miltenyi
Biotec). NK cells were between 90–99% CD3
 
 
 
, CD56
 
 
 
, and
2B4
 
 
 
. The cells were cultured as described previously (31). Cell
lines 721.221, 221-Cw3, and 221-Cw4 (a gift from J. Gumperz
 
and P. Parham, Stanford University, Palo Alto, CA) were main-
tained as described (32). The human NK cell line YTS-2DL1
(reference 33; gift from G. Cohen, Massachusetts General Hospi-
tal, Charlestown, MA) was cultured in Iscove’s medium supple-
mented with 10% FCS, 
 
l
 
-glutamine, and 2 
 
 
 
g/ml Puromycin.
P815 cells (American Type Culture Collection) were maintained
in Iscove’s medium with 10% FCS and 
 
l
 
-glutamine.
 
Antibodies.
 
The mAb Leu-19 is specific for CD56 (Becton
Dickinson). The mAb C1.7 (IgG1) (Beckman Coulter) is specific
for human 2B4 (23, 34); MOPC-21 (Sigma-Aldrich) served as a
mouse IgG1 control. Affinity-pure and HRP-conjugated goat
anti–mouse IgG was purchased from Jackson ImmunoResearch
Laboratories. Peroxidase-conjugated goat anti–rabbit antibodies
were from Santa Cruz Biotechnology, Inc. and the monoclonal
anti-CD45 antibody was purchased from Transduction Laborato-
ries. The biotin-conjugated anti-phosphotyrosine specific anti-
body 4G10 (IgG2b) was purchased from Upstate Biotechnology.
Peroxidase-conjugated cholera toxin B-subunit was from Sigma-
Aldrich. The rabbit anti-KIR2DL1 and anti-2B4 antibodies have
been described (24, 35).
 
Inhibitors.
 
For cholesterol depletion, purified human NK cells
or YTS cells were washed three times in PBS and incubated for
30 min at 37
 
 
 
C with 7.5 mM (for YTS cells) or 12.5 mM (for hu-
man NK cells) Methyl-
 
 
 
-Cyclodextrin (MCD; Sigma-Aldrich) in
PBS. Subsequently, cells were washed in PBS/0.2% BSA and
used for cytotoxicity assay or cell mixing (both using medium
with 0.2% BSA instead of FCS), or recovered for 3 h in complete
medium containing 10% FCS. Actin polymerization was blocked
by treating cells with 10 
 
 
 
M Cytochalasin D, 2 
 
 
 
M Latrunculin
A, or 1 
 
 
 
M Jasplakinolide (all Molecular Probes or Sigma-Aldrich)
for 30 min at 37
 
 
 
C. Actin was depolymerized in cell lysates by in-
cubating the lysate with 20 
 
 
 
M Cytochalasin D and 20 
 
 
 
M La-
trunculin A for 60 min at 4
 
 
 
C.
 
Raft Isolation.
 
For antibody stimulation, 10
 
8
 
 YTS-2DL1 cells
per sample were used. For cell mixing, 5 
 
 
 
 10
 
7
 
 YTS-2DL1 cells
and 5 
 
 
 
 10
 
7
 
 221 cells were used. Due to the very high cell num-
bers necessary for this assay, the use of purified polyclonal human
NK cells was limited. For cell mixing, 3 
 
 
 
 10
 
8
 
 human NK cells
and 6 
 
 
 
 10
 
7
 
 221 cells per sample were used. After stimulation or
mixing, cells were lysed in 1 ml ice-cold TNEV buffer (10 mM
Tris/Cl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 1 mM PMSF, 1
mM N
 
3
 
VO
 
4
 
) containing 1% Triton X-100 for 30 min on ice.
Lysates were homogenized with 10 strokes of a loose fit Dounce
homogenizer and mixed with 1 ml 85% wt/vol sucrose in
TNEV. Samples were transferred to an ultracentrifuge tube and
overlaid with 6 ml 35% followed by 3.5 ml 5% wt/vol sucrose in
TNEV. Samples were centrifuged at 200,000 
 
g
 
 for 16 h at 4
 
 
 
C. 1
ml fractions were collected from the top of the tube and neigh-
boring fractions (2
 
 
 
3, 4
 
 
 
5 etc.) were combined to reduce the
number of samples during analysis. Fractions were then analyzed
by immunoprecipitation, Western blotting, or enzymatic assay.
To follow the distribution of 2B4 after cross-linking with an
HRP-conjugated antibody, a colorimetric substrate assay for
HRP activity was used: 50 
 
 
 
l of each fraction were mixed in an
ELISA plate with 100 
 
 
 
l of substrate solution (Sigma Fast o-Phe-
nylendiamine Dihydrochloride; Sigma-Aldrich) and reactions
were stopped by adding 50 
 
 
 
l 3 M H
 
2
 
SO
 
4
 
. For analysis, absorp-
tion at 490 nm was measured.
 
Receptor Cross-linking, Cell Mixing, Immunoprecipitation, and
Western Blotting.
 
For antibody-mediated cross-linking of 2B4,
NK cells were incubated with 10 
 
 
 
g/ml control IgG1 or C1.7 in
medium for 10 min on ice. After addition of 15 
 
 
 
g/ml goat
anti–mouse antibodies (containing a tracer amount of HRP-con-T
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jugated goat anti–mouse antibodies in some cases) cells were
transferred to 37
 
 
 
C for the indicated times. Cells were then
chilled on ice, pelleted by centrifugation, and rafts were isolated
as described above.
For cell mixing, NK cells and target cells were mixed at an ef-
fector to target ratio of 1 (YTS-2DL1) or 2 (human NK cells) and
pelleted by centrifugation. Cells were incubated on ice for 10
min and then transferred to 37
 
 
 
C for 5 min. Cells were then
chilled on ice, pelleted by centrifugation, and lysed in ice-cold ly-
sis buffer (0.5% Triton X-100, 20 mM Tris/Cl pH 7.4, 150 mM
NaCl, 10% Glycerin, 2 mM EDTA, 1 mM PMSF, 10 mM NaF,
and 1 mM NaVO
 
4
 
) for 20 min on ice. Lysate was cleared by cen-
trifugation (14,000 rpm, 4
 
 
 
C, 15 min).
For immunoprecipitation lysates or raft fractions mixed 1:1
with lysis buffer were first incubated with 2 
 
 
 
g control IgG1
coupled to protein G agarose followed by 2 
 
 
 
g anti-2B4 anti-
body (C1.7 or rabbit anti-2B4) coupled to protein G agarose.
Beads were washed three times in 20 vol of ice-cold lysis buffer
and boiled in reducing 2
 
  
 
SDS sample buffer.
For Western blotting, samples were separated on a 10–20%
SDS gel (Novex) and transferred to a PVDF membrane (Immo-
bilon P; Millipore). The membrane was blocked with 5% BSA
in TPBS (0.05% Tween-20 in PBS) for 1 h at room temperature
followed by an incubation with the indicated antibodies (rab-
bit anti-2B4, biotinylated 4G10, anti-CD45, or rabbit anti-
KIR2DL1; all 1 
 
 
 
g/ml in 5% BSA/TPBS) for 16 h at 4
 
 
 
C. After
washing, the membrane was incubated with the respective
HRP-conjugated secondary antibodies or peroxidase-conju-
gated cholera toxin B-subunit (8 
 
 
 
g/ml) and developed using
Super Signal West Dura Extended Duration Substrate (Pierce
Chemical Co.).
 
51
 
Cr Release Assay.
 
Target cells were grown to mid-log phase
and 5 
 
 
 
 10
 
5
 
 cells were labeled in 100 
 
 
 
l CTL medium (Iscove’s
medium supplemented with 10% FCS, 
 
l
 
-glutamine, and Pen/
Strep) with 100 
 
 
 
Ci 
 
51
 
Cr for 1 h at 37
 
 
 
C. Cells were washed
twice in CTL medium and resuspended at 5 
 
 
 
 10
 
4
 
 cells/ml in
CTL medium. 5,000 target cells/well were used in the assay. Ef-
fector cells were resuspended in CTL medium supplemented
with 100 U/ml recombinant IL-2 and, where applicable, prein-
cubated with antibodies (0.5 
 
 
 
g/ml final concentration) for 15
min at 25
 
 
 
C. After preincubation effector cells were mixed with
labeled target cells in a V-bottom 96-well plate. Maximum re-
lease was determined by incubation in 1% Triton X-100. For
spontaneous release targets were incubated without effectors in
CTL medium alone. All samples were done in triplicate. After a
1-min centrifugation at 1,000 rpm plates were incubated for 3 h
at 37
 
 
 
C. Supernatant was harvested and 
 
51
 
Cr release was mea-
sured in a gamma counter. % specific release was calculated as
([experimental release 
 
 
 
 spontaneous release]/[maximum release 
 
 
 
spontaneous release]) 
 
 
 
 100. The ratio between maximum and
spontaneous release was at least 4 in all experiments.
 
Results
 
Phosphorylated 2B4 Is Found Exclusively in the DRM Frac-
tion.
 
2B4 phosphorylation can be induced by antibody-
mediated cross-linking (28) or by mixing of NK cells with
CD48
 
 
 
 target cells (24). Coengagement of inhibitory re-
ceptors blocks 2B4 phosphorylation (24), indicating that
ITIM-bound SHP-1 may operate upstream of receptor
phosphorylation or may dephosphorylate 2B4 directly. We
therefore investigated the signaling pathways leading to
 
2B4 phosphorylation. We have previously shown that tar-
get cell–induced 2B4 phosphorylation is dependent on
Src-family kinases (3). Several of the Src-family kinases are
associated with liquid-ordered membrane domains that are
enriched in glycosphingolipids and cholesterol, and are re-
ferred to as rafts (9). We therefore tested if engagement of
2B4 resulted in its translocation to such rafts. Cells were
incubated in the presence of antibodies for 5 min at 37
 
 
 
C,
cooled to 4
 
 
 
C, and solubilized in 1% Triton X-100–con-
taining lysis buffer, conditions under which clustered rafts
are insoluble. Clustered rafts were then floated by sucrose
density gradient centrifugation, which by definition iso-
lates DRM domains (9), and gradient fractions were ana-
lyzed by Western blotting. In control-treated NK cells (in
which CD56 was cross-linked with antibodies) 2B4 was
found exclusively in the soluble membrane fraction
whereas antibody-mediated cross-linking of 2B4 resulted
in the association of a fraction of 2B4 with the DRM (Fig.
1
 
 
 
A). CD45 was present in the detergent soluble fraction
Figure 1. Phosphorylated 2B4 is found exclusively in DRM domains.
(A) The CD16-negative human NK cell line YTS was stimulated with
antibodies against CD56 or 2B4 that were cross-linked with a secondary
antibody for 5 min at 37 C. Subsequently, cells were lysed and DRM iso-
lated by sucrose gradient centrifugation. Neighboring fractions were
combined and analyzed by Western blotting using antibodies against 2B4
(top panel), CD45 (middle panel), or HRP-conjugated cholera toxin
B-subunit (CTx, bottom panel). CD45 is a marker for the soluble frac-
tion (10/11) while CTx marks the DRM fraction (4/5). (B) YTS cells
were stimulated with an antibody against 2B4 and cross-linked with a
mixture of unlabeled and HRP-conjugated secondary antibody for the
indicated time at 37 C. After DRM isolation the different fractions were
analyzed for the presence of HRP activity using a colorimetric substrate
assay followed by photometric analysis. (C) The DRM (4/5) and the sol-
uble fractions (10/11) from the samples shown in panel A were immuno-
precipitated using an anti-2B4 antibody and analyzed by anti-phosphoty-
rosine Western blotting.T
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and the ganglioside GM1, a resident raft component de-
tected by cholera toxin B subunit, was present in the
DRM (Fig. 1 A, bottom panels). To more easily follow the
distribution of 2B4 after antibody cross-linking an en-
zyme-based assay was developed: 2B4 was cross-linked us-
ing an anti-2B4 mAb and a mixture of peroxidase-conju-
gated and unlabeled goat anti–mouse IgG antibodies. After
DRM isolation the distribution of 2B4 was determined by
analyzing the different fractions for peroxidase activity us-
ing a colorimetric substrate assay. The data of this enzyme-
based raft assay were comparable to those obtained by
Western blot analysis (data not depicted). In a kinetic anal-
ysis association of 2B4 with DRM (fraction #4) after anti-
body-mediated cross-linking peaked at around 5 min at
37
 
 
 
C (Fig. 1 B). The time course of DRM recruitment of
2B4 was reminiscent of the kinetics observed for 2B4
phosphorylation after antibody-mediated cross-linking
(24). The phosphorylation status of soluble and of DRM-
associated 2B4 was therefore investigated. 2B4 was immu-
noprecipitated from the samples shown in Fig. 1 A and an-
alyzed by anti-phosphotyrosine Western blotting (Fig. 1
C). Phosphorylated 2B4 was found exclusively in the
DRM fractions. It is interesting to note that even in con-
trol-treated cells the low level of phosphorylated 2B4 was
also located in DRM (Fig. 1 C).
To validate these findings in a more physiological set-
ting, purified polyclonal human NK cells were mixed with
the CD48
 
 
 
 MHC class I–negative target cell 721.221.
Without mixing (0’), no 2B4 was detectable in the DRM
domain (Fig. 2, lane 4). Similar to the results with anti-
body-mediated cross-linking, a fraction of 2B4 was de-
tected in DRM 5 min after target cell mixing (Fig. 2, lane
9) and only this fraction of 2B4 was tyrosine phosphory-
lated. This suggests that after activation, some of the 2B4
receptor is concentrated in rafts where it can be phosphor-
ylated by raft-associated Src kinases.
 
Rafts Are Essential for 2B4 Phosphorylation and Function.
 
The exclusive localization of phosphorylated 2B4 in
DRM suggests that rafts may be essential for the function
and phosphorylation of 2B4. To test this, purified poly-
clonal human NK cells were depleted of cholesterol by
treatment with MCD, which results in the disruption of
rafts. Cholesterol depletion completely blocked the killing
of 721.221 target cells (Fig. 3 A), confirming that rafts are
essential to the activation of natural killing in NK cells (7).
To demonstrate that this effect was reversible, cholesterol-
depleted NK cells were allowed to recover in cholesterol-
containing medium for 3 h, which completely restored
their natural killing ability (Fig. 3 A). In addition to natu-
ral killing, 2B4-mediated NK cell activation, determined
in a redirected lysis assay was completely disrupted by cho-
lesterol depletion (Fig. 3 B), an effect that also was revers-
ible. Similar data were obtained using the NK cell line
YTS-2DL1 (data not depicted). This result demonstrated
that rafts are essential for the ability of 2B4 to activate NK
cells. But are rafts necessary for the phosphorylation of
2B4? To test this, the NK cell line YTS was control-
treated, cholesterol-depleted, or cholesterol-depleted and
allowed to recover. 2B4 was then cross-linked by antibod-
ies and DRM fractions were isolated. As expected, no
DRM fraction could be isolated from MCD-treated cells
as evident from the CTx blot (Fig. 4 A, bottom panel).
Therefore, also no DRM recruitment of 2B4 was ob-
served in cholesterol-depleted cells whereas recovered
cells showed normal DRM recruitment of 2B4 (Fig. 4 A,
top panel). To test for 2B4 phosphorylation, the 2B4 blot
was reprobed using an anti-phosphotyrosine antibody
(Fig. 4 A, middle panel). While 2B4 cross-linking induced
2B4 phosphorylation in the DRM fraction in control-
Figure 2. Target cell contact induces recruitment of 2B4 into DRM
domains. Purified polyclonal human NK cells and 721.221 cells were ei-
ther incubated separately (0 ) or mixed (5 ) for 5 min at 37 C. After cell
lysis, DRM was isolated, neighboring fractions were combined and
immunoprecipitated using a control antibody (IgG1) followed by anti-
2B4 immunoprecipitation (2B4). Samples were analyzed by anti-2B4
Western blotting (2B4) and reblotted using an anti-phosphotyrosine anti-
body (2B4-P). DRM isolation was monitored by analyzing the different
fraction using an anti-CD45 antibody and HRP-conjugated cholera toxin
B-subunit (CTx).
Figure 3. Lipid rafts are essential for NK cell activation and 2B4 func-
tion. (A and B) Purified polyclonal human NK cells were control-treated
or cholesterol-depleted using MCD and analyzed either immediately or
after a 3 h recovery in complete medium. Cells were analyzed in a 51Cr-
release assay using 721.221 target cells (A) or in a redirected lysis assay us-
ing P815 target cells (B) coated with control antibody (open symbols) or
anti-2B4 antibody (filled symbols).T
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treated and recovered cells, no 2B4 phosphorylation could
be observed in cholesterol-depleted cells. However, other
phosphorylated proteins in the soluble fractions made a
clear analysis of 2B4 phosphorylation difficult. Therefore,
2B4 was immunoprecipitated from the DRM (4/5) and
the soluble fractions (10/11) and analyzed by anti-phos-
photyrosine Western blotting (Fig. 4 B). Again, no 2B4
phosphorylation was observed after 2B4 cross-linking in
cholesterol-depleted cells (Fig. 4 B), suggesting that rafts
are essential for the phosphorylation of 2B4.
The importance of lipid rafts for the phosphorylation of
2B4 could be explained in two ways: (a) stimulation of 2B4
leads to its recruitment to rafts where 2B4 is phosphory-
lated, or (b) 2B4 is phosphorylated outside of rafts upon
stimulation and moves into rafts where it is protected from
dephosphorylation by phosphatases. The second explana-
tion would suggest that phosphorylation of 2B4 induces its
recruitment to rafts. To test this, 2B4 phosphorylation was
induced by pervanadate, an inhibitor of tyrosine phos-
phatases, and DRM domains were isolated. As expected,
pervanadate treatment induced very strong 2B4 phos-
phorylation (Fig. 5). Furthermore, phosphorylated 2B4 was
found in the soluble fractions (Fig. 5). This result makes it
unlikely that DRM recruitment of 2B4 occurs simply as a
result of 2B4 phosphorylation and suggests that a specific
signal is needed to recruit 2B4 to rafts, where it becomes
phosphorylated. However, we cannot exclude the possibil-
ity that pervanadate induces phosphorylation of different
residues on 2B4 than those induced by the physiological
ligand of 2B4.
 
KIR Blocks Phosphorylation and DRM Recruitment of 2B4.
 
We have previously shown that inhibitory receptors block
2B4 phosphorylation (24). Here we have demonstrated
that phosphorylated 2B4 is found exclusively in DRM
domains. How do inhibitory receptors influence the
recruitment of 2B4 into lipid rafts? To test this the YTS
cell line stably expressing the inhibitory receptor KIR2DL1
(YTS-2DL1) was used (33). KIR2DL1 recognizes HLA-
Cw4 but not HLA-Cw3 (32, 36). Therefore, 721.221 cells
expressing Cw3 (221-Cw3) are sensitive to killing by YTS-
2DL1 while 721.221 cells expressing Cw4 (221-Cw4) are
protected (24). YTS-2DL1 cells were mixed either with
221-Cw3 or 221-Cw4 cells, both expressing equal levels of
CD48 (unpublished data), and DRMs were isolated. As
seen with polyclonal human NK cells (Fig. 2), mixing of
YTS-2DL1 cells with the sensitive target 221-Cw3 resulted
in the recruitment of 2B4 into DRM domains (Fig. 6 A).
In contrast, DRM recruitment of 2B4 was blocked by the
engagement of KIR2DL1 after mixing YTS-2DL1 with
221-Cw4 cells (Fig. 6 A). Similar results were obtained us-
ing antibodies to specifically cross-link 2B4 with or with-
out cocross-linking of KIR2DL1 (data not depicted). Fur-
thermore, engagement of KIR2DL1 by antibodies or by
binding to its ligand HLA-Cw4 on target cells did not re-
sult in KIR2DL1 recruitment to DRM (Fig. 6 A, and data
not depicted). As expected, tyrosine phosphorylated 2B4 in
YTS-2DL1 cells mixed with 221-Cw3 cells was found in
DRM fractions (Fig. 6 B). The reduced amount of phos-
phorylated 2B4 observed after KIR2DL1 engagement by
HLA-Cw4 was also resident in DRM (Fig. 6 B). There-
fore, KIR2DL1 appears to prevent phosphorylation of 2B4
by blocking the recruitment of 2B4 into rafts rather than by
counteracting Src-kinases through targeting of active SHP-1
to rafts.
 
Phosphorylation and DRM Recruitment of 2B4 Depend on
the Actin Cytoskeleton.
 
As rafts are instrumental for 2B4
phosphorylation it is unlikely that KIR-bound SHP-1 de-
phosphorylates 2B4 directly considering that KIR is not re-
cruited to the DRM. Therefore, KIR may block 2B4
Figure 4. Lipid rafts are essential for 2B4 phosphorylation. (A) The NK
cell line YTS was treated with MCD as described in Fig. 3 and stimulated
with a control antibody (CD56) or an anti-2B4 antibody and analyzed as
described in Fig. 1 A (top panel), and reblotted with an anti-phosphoty-
rosine antibody (middle panel). DRM isolation was monitored by analyz-
ing the different fraction using an anti-CD45 antibody (unpublished data)
and HRP-conjugated cholera toxin B-subunit (bottom panel). (B) The
DRM (4/5) and the soluble fractions (10/11) from the samples shown in
panel A were immunoprecipitated using an anti-2B4 antibody and ana-
lyzed by anti-phosphotyrosine Western blotting.
Figure 5. Accumulation of phosphorylated 2B4 outside of DRM do-
mains after pervanadate treatment. The NK cell line YTS was treated
with PBS ( ) or 100  M pervanadate ( ) in PBS for 10 min at 37 C and
DRM was isolated. The DRM fraction (4/5) and the detergent soluble
fraction (10/11) were immunoprecipitated with a control antibody
(IgG1) followed by anti-2B4 immunoprecipitation. Samples were ana-
lyzed by Western blotting using an rabbit anti-2B4 antibody (top panel)
and reblotted with an anti-phosphotyrosine antibody (bottom panel).T
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phosphorylation and recruitment to DRM domains by in-
terfering with a signaling event necessary for the recruit-
ment of 2B4 into clustered rafts. 2B4 clusters at the target
cell interface when NK cells adhere to CD48
 
 
 
 target cells
(unpublished data). During this process, lipid rafts also clus-
ter and concentrate at the site of target cell contact (7, 8).
The actin cytoskeleton is required for the clustering of lipid
rafts in T cells and NK cells (8, 37). To test if a link exists
between the actin cytoskeleton and the recruitment of 2B4
to DRM, the effect of different inhibitors was evaluated.
Recruitment of 2B4 into DRM after antibody-mediated
cross-linking was unaffected by inhibitors that block PI3-
kinase (Wortmannin) or Syk/ZAP70 kinases (Piceatannol;
Fig. 7). In contrast, inhibition of Src-family kinases by PP1,
which was shown to effectively block 2B4 phosphorylation
(3), blocked recruitment of 2B4 into DRM. Blocking ac-
tin cytoskeleton reorganization by Cytochalasin D also
blocked recruitment of 2B4 into DRM (Fig. 7). The
DRM recruitment of 2B4 induced by mixing of polyclonal
human NK cells with 721.221 targets was also blocked by
Cytochalasin D (data not depicted). This result demon-
strated that, like the clustering of lipid rafts at the target cell
interface, the recruitment of 2B4 to DRM is dependent on
the actin cytoskeleton.
The requirement for actin polymerization in the recruit-
ment of 2B4 to DRM may be secondary to the effect of
the actin cytoskeleton on clustering of lipid rafts (8, 37).
Alternatively, F-actin may also contribute directly to the
association of 2B4 with lipid rafts. To test this possibility,
F-actin was depolymerized after cell lysis before fraction-
ation of DRM by sucrose gradient by using a combination
of Cytochalasin D and Latrunculin A. Cytochalasin D
binds to the barbed end of actin and leads to the cleaving of
actin filaments (38), whereas Latrunculin A disrupts mi-
crofilament organization by binding to monomeric G-actin
(39). If the association of 2B4 with lipid rafts depends on
F-actin–mediated interactions, actin depolymerization
would eliminate 2B4 from DRM. However, F-actin depo-
lymerization had no effect on the association of 2B4 with
DRM after cell lysis (data not depicted).
These data place actin polymerization upstream of 2B4
recruitment to DRM, which is necessary for 2B4 phos-
phorylation. Blocking actin polymerization should there-
fore also affect 2B4 phosphorylation. Three inhibitors af-
fecting different events during actin polymerization were
used to test their effect on 2B4 phosphorylation, Cytocha-
lasin D, Latrunculin A, and Jasplakinolide which induces
nonspecific actin polymerization by affecting the induction
of actin filament nucleation (40). All three inhibitors effec-
tively blocked 2B4 phosphorylation in purified polyclonal
human NK cells that were mixed with 721.221 cells (Fig. 8
A), confirming that reorganization of the actin cytoskeleton
is necessary for the raft-dependent phosphorylation of 2B4.
In the same experiment, 2B4 phosphorylation induced by
pervanadate was not blocked by the actin cytoskeleton in-
hibitors, which excludes nonspecific effects on tyrosine
phosphorylation (Fig. 8 B).
These data demonstrate that the KIR-mediated inhibi-
tion of 2B4 phosphorylation occurs upstream of 2B4 phos-
phorylation by blocking the recruitment of 2B4 to DRM
domains. This is consistent with data showing that KIR en-
gagement can block raft clustering at the target cell interface
(7, 8). As the clustering of rafts and the DRM recruitment
of 2B4 depend on the actin cytoskeleton, an effective
mechanism for the inhibition of NK cell activation may be
a block of early actin reorganization by inhibitory receptors.
Figure 6. KIR2DL1 blocks DRM recruitment and phosphorylation of
2B4. YTS-2DL1 cells and 221-Cw3 or 221-Cw4 cells were either incu-
bated separately (0 ) or together (5 ) for 5 min at 37 C. After cell lysis
DRM was isolated, neighboring fractions were combined and analyzed by
Western blotting using antibodies against 2B4 (top panel) or KIR2DL1
(bottom panel). DRM isolation was monitored by analyzing the different
fraction using an anti-CD45 antibody and HRP-conjugated cholera toxin
B-subunit as in Figs. 1 and 2 (unpublished data). (B) The DRM (4/5) and
the soluble fractions (10/11) from the samples shown in panel A were
immunoprecipitated (IP) using a control antibody (IgG1) followed by an
anti-2B4 antibody (2B4) and analyzed by anti-2B4 Western blotting (2B4)
and reblotted using an anti-phosphotyrosine antibody (2B4-P).
Figure 7. Recruitment of 2B4 to DRM domains is dependent on Src-
family kinases and on actin polymerization. The CD16-negative human
NK cell line YTS was treated for 30 min at 37 C with carrier only
(DMSO) or the indicated inhibitors. Subsequently, cells were stimulated
by an anti-2B4 antibody and analyzed as described in Fig. 1 B. Gradient
fractions from DMSO- and Cytochalasin D–treated cells were also ana-
lyzed by Western blotting which confirmed the result for the distribution
of 2B4 and demonstrated that Cytochalasin D treatment does not affect
the integrity and isolation of DRM fractions (unpublished data).T
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Discussion
Inhibitory receptors effectively prevent NK cell activa-
tion induced by a variety of different surface receptors (3).
The activity of the tyrosine phosphatase SHP-1, which is
recruited by the phosphorylated ITIMs in the cytoplasmic
tail of KIR and CD94/NKG2A, is essential for this inhibi-
tion. Here we used the activating receptor 2B4 and its
ligand CD48 as a model system to study how inhibitory re-
ceptors interfere with activation signals. We had previously
shown that inhibitory KIR and CD94/NKG2A receptors
block 2B4 phosphorylation (24), placing the activity of
ITIM-bound SHP-1 upstream, or at the level of 2B4 re-
ceptor phosphorylation. This report now demonstrates that
inhibitory receptors block the actin cytoskeleton-depen-
dent recruitment of 2B4 into lipid rafts (as defined by asso-
ciation with DRM domains), which is itself essential for
2B4 phosphorylation and function.
2B4 phosphorylation is the first detectable step in 2B4
signaling. Phosphorylated 2B4 binds SAP, SHP-1, SHP-2,
and LAT. However, it is still unclear how 2B4 can activate
NK cells: SAP, while necessary for 2B4 function (27, 41–
43), does not contain any known enzymatic activity. The
only described function for SAP in 2B4 signaling is to block
the recruitment of the phosphatases SHP-1 and SHP-2 (27,
41). The localization of 2B4 in lipid rafts does not only ex-
plain its Src-family kinase dependent phosphorylation, but
could also explain how 2B4 can lead to NK cell activation:
rafts are signaling platforms rich in kinases and adaptor mol-
ecules that may be used by 2B4 to transmit its signal. Cho-
lesterol depletion inhibited not only 2B4-mediated NK cell
activation, but also natural killing of 721.221 targets (Fig. 3
A) which depends on the activation receptors NKp44 and
NKp46 (44, 45). The function of these and other activating
receptors may therefore also depend on lipid rafts.
2B4 is constitutively associated with the adaptor mole-
cule LAT (28, 29). But how can 2B4 associate with LAT,
which is constitutively associated with rafts in T cells (46),
when the raft retention of 2B4 is activation dependent? In-
terestingly, using our DRM isolation method we found
that a major fraction of LAT resides outside of DRM do-
mains in NK cells and that target cell contact increased the
DRM association of LAT (unpublished data). This discrep-
ancy of LAT localization could be explained by different
raft isolation methods or by a difference between T and
NK cells. The association of 2B4 with LAT could be ex-
plained in two ways: (a) 2B4 and LAT associate directly
through protein–protein interactions and move together in
and out of rafts. Accordingly, LAT may be directly in-
volved in the raft recruitment of 2B4. (b) Even in nonstim-
ulated cells 2B4 and LAT colocalize in some DRM do-
main, which does not float to the lighter density fraction in
our sucrose density centrifugation. NK cell activation
would then result in the formation of larger raft clusters
that can be isolated biochemically, consistent with a recent
model (9). After submission of this manuscript Klem et al.
reported that the association of mouse 2B4 with LAT is de-
pendent on the localization of 2B4 in lipid rafts (47), favor-
ing the second explanation for the association between hu-
man 2B4 and LAT.
Rafts are essential for the phosphorylation of 2B4 (Fig. 4
B). Even in nonstimulated cells traces of phosphorylated
2B4 are found exclusively in DRM domains (Fig. 1 C).
Only after inhibition of tyrosine phosphatases with pervan-
adate was phosphorylated 2B4 detected outside of DRM
(Fig. 5). These observations suggest a dynamic balance of
2B4 inside and outside of rafts. In this model, 2B4 moves
into rafts where it is phosphorylated by Src-family kinases.
In nonstimulated cells phosphorylated 2B4 quickly moves
out of rafts and is dephosphorylated by phosphatases such
that at any given time only a very small fraction of phos-
phorylated 2B4 can be found in rafts. Antibody-mediated
cross-linking of 2B4 or contact with CD48  target cells
stabilizes 2B4 in clustered rafts and phosphorylated 2B4 can
accumulate. It may therefore be more correct to assume
that 2B4 is retained in rafts rather than being recruited to
rafts. The actin cytoskeleton-dependence of the association
of phosphorylated 2B4 with DRM may reflect the known
role of the cytoskeleton in the maintenance of raft cluster-
ing. F-actin is not directly involved in raft retention of 2B4
because actin depolymerization after cell lysis did not re-
duce the amount of 2B4 associated with the DRM. The
molecular basis for the association of phosphorylated 2B4
with DRM is still unknown. Interestingly, both human
and mouse 2B4 contain a conserved cysteine motif (Cys-
Phe-Cys) at the cytoplasmic end of their transmembrane
domain. A recent report demonstrated that this cysteine
motif is essential for the localization of mouse 2B4 in lipid
rafts (47), suggesting that palmitoylation of 2B4 contributes
to this process.
The identification of a cytoskeleton-dependent raft re-
cruitment of 2B4 can give an important insight into the
mechanism by which inhibitory receptors control 2B4
phosphorylation and NK cell activation. KIR can inhibit
clustering of rafts (7, 8) and retention of 2B4 in DRM
Figure 8. 2B4 phosphorylation is dependent on the actin cytoskeleton.
(A) Purified polyclonal human NK cells were treated for 30 min at 37 C
with carrier only (DMSO) or the indicated inhibitors. Subsequently, cells
were either incubated separately (0 ) or after mixing with 721.221 cells
(5 ) for 5 min at 37 C. After lysis, samples were immunoprecipitated us-
ing a control antibody (IgG1, shown is the DMSO-treated sample after
target cell mixing and 5  incubation) followed by an anti-2B4 antibody.
Immunoprecipitates were analyzed by anti-phosphotyrosine Western
blotting (2B4-P) and reblotted using an anti-2B4 antibody (2B4). (B) The
same cells described in panel A were treated with pervanadate, lysed,
immunoprecipitated, and analyzed as described for panel A.T
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without being recruited to DRM itself (Fig. 6). As the sta-
bilization of 2B4 in DRM is dependent on the actin cyto-
skeleton, a likely target of inhibition by KIR are signals
necessary for actin polymerization. Interference with actin
polymerization by the engagement of an inhibitory recep-
tor has been shown in T cells (48).
Our data suggests that the control of 2B4 phosphoryla-
tion by inhibitory receptors operates indirectly through an
early block in actin polymerization, thereby preventing
the stabilization of 2B4 in lipid rafts. Blocking actin poly-
merization has been shown to inhibit signaling from other
surface receptors such as the TCR (49), whose signaling is
also dependent on lipid rafts (10). The use of immunore-
ceptor tyrosine-based activation motif ( ITAM)-contain-
ing partner chains by the TCR is reminiscent of other NK
cell activating receptors such as NKp30, NKp44, and
NKp46. This suggests that the model proposed here for
the control of 2B4-mediated NK cell activation could
serve as a general explanation of how inhibitory receptors
control T cell and NK cell activation mediated by a vari-
ety of surface receptors.
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